In Vitro Diagnostics
(IVD) Quality Control Market Worth 1,065.3 Million USD By 2022
As per the report titled
as “In
Vitro Diagnostics (IVD) Quality Control Market–Global Opportunity
Analysis and Industry Forecast (2017-2022)”, the global IVD quality controls
market will grow at a CAGR of 3.8% during the forecast period to reach USD
1,065.3 million by 2022. The global In Vitro Diagnostics Quality Controls
Market is driven by the increasing number of accredited clinical laboratories,
growing demand for external quality assessment (EQA) support, and increasing
mandates from regulatory & accreditation bodies on the use of quality
controls. However, additional costs burden associated with quality controls on
laboratories, unfavorable reimbursement scenario for IVD tests, and lack of
mandatory regulations for clinical laboratory accreditation in many emerging
countries is expected to restrain the growth of this market to a certain
extent.
Browse
in-depth report at //www.meticulousresearch.com/product/ivd-in-vitro-diagnostics-quality-controls-market-2022/
The global IVD quality
controls market is majorly segmented by product type, application, end user,
manufacturer type, and geography. Based on product type, the IVD quality
controls market is majorly segmented into quality controls, data management
software, and external quality assurance services. Quality Controls segment
held the largest share in the global IVD quality controls market in 2016, owing
to the increasing adoption of control materials with high stability to check
the accuracy & precession of laboratory testing process and IVD tests
results.
Based on application, the
IVD quality controls market is majorly segmented into clinical chemistry,
hematology, immunoassay, molecular diagnostics, microbiology,
coagulation/hemostasis, and others. The immunoassay segment accounted for the
largest share of the global IVD quality controls market in 2016 and is also
expected to continue its dominance during the forecast period. The large share
of this segment is attributed to the higher adoption of high sensitive and
cost-effective immunoassay tests for the diagnosis of increasing infectious
diseases and relatively increased demand for multi-analyte immunoassay controls
to ensure the accuracy & reliability of immunoassay test menus
On the basis of end
user, the In Vitro Diagnostics Quality Controls Market is majorly segmented
into hospitals, clinical/ reference laboratories, research & academic
institutes, and others. Hospitals segment held the largest share in the global
IVD quality controls market in 2016. The largest share of this segment is
mainly attributed to the large share of diagnostics tests performed in the
hospital attached laboratories and relatively higher demand for quality
controls in these healthcare settings to ensure the accuracy and reliability of
IVD test results of the patients.
Based on manufacturer
type, the IVD quality controls market is majorly segmented into IVD instrument
manufacturers and third party quality control manufacturers.Third party quality
control manufacturers commanded the largest share in the global IVD quality
controls market in 2016. The largest share of this segment is attributed to the
increasing demand for multi-analyte third party controls to obtain an unbiased
opinion on the analytical performance of the laboratory.
Speak-To-Analyst:
https://www.meticulousresearch.com/speak-to-analyst/?cp_id=3447
Based on geography, this
market is majorly segmented into six regions: North America, Europe,
Asia-Pacific, Latin America, Middle East, and Africa. North America holds the
major share in the global IVD quality controls market, followed by Europe and
Asia-Pacific region.The major share of North America is mainly attributed to
the rising number of accredited laboratories, stringent rules and regulations
on quality assurance in the region, higher adoption of innovative multi-analyte
third party controls and related products & services, and well-established
healthcare system & distribution channels in the U.S. However, Asia-Pacific
region is projected to show lucrative growth potential for the In Vitro
Diagnostics Quality Controls Market during the analysis period, owing to the
significantly growing IVD industry in the region with rising demand for early
diagnosis from large patient population in Asia, rising number of accredited
laboratories, increasing number of hospitals and clinical pathologies,
increasing healthcare spending, and improving healthcare infrastructure in the
region.
The major players
operating in the global In Vitro Diagnostics Quality Controls Market are Randox
Laboratories Ltd. (U.K.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad
Laboratories Inc. (U.S.), Technopath Clinical Diagnostics (Ireland), SeraCare
Life Sciences Inc. (U.S.), Merck KGaA (Germany), Maine Molecular Quality
Controls, Inc. (U.S.), Sero AS (Norway), Eurotrol B.V. (The Netherlands), Omega
Diagnostic Group PLC (U.K.), Fortress Diagnostic Limited (U.K.), Sun
Diagnostics, LLC. (U.S.), Siemens AG (Germany), Abbott Laboratories (U.S.), F.
Hoffmann-La Roche Ltd. (Switzerland), Helena Biosciences Europe (U.K.), Danaher
Corporation (U.S.), Ortho Clinical Diagnostics (U.S.), ZeptoMetrix Corporation
(U.S.), and Becton, Dickinson and Company (U.S.).
Download-Sample-Report
:
https://www.meticulousresearch.com/download-sample-report/?cp_id=3447
About Meticulous Research
Meticulous
Research® is founded in 2010 and incorporated
as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company
under the Companies Act, 1956. Since its incorporation, the company has become
the leading provider of premium market intelligence in North America, Europe,
Asia-Pacific, Latin America, and Middle East & Africa.
Contact Us:
Viren Shrivastava
Viren Shrivastava
AVP- Global Sales and Marketing
Meticulous Research®
Tel: +1-646-781-8004
Comments
Post a Comment